The Epidermal Growth Factor Receptor ligand Amphiregulin has a well-documented role in the restoration of tissue homeostasis following injury; however, the mechanism by which Amphiregulin contributes to wound repair remains unknown. Here we show that Amphiregulin functions by releasing bio-active TGFb from latent complexes via integrin-αv activation. Using acute injury models in two different tissues, we found that by inducing TGFb activation on mesenchymal stromal cells (aka pericytes), Amphiregulin induced their differentiation into myo-fibroblasts, thereby selectively contributing to the restoration of vascular barrier function within injured tissue. Furthermore, we identified macrophages as a critical source of Amphiregulin, revealing a direct effector mechanism by which these cells contribute to tissue restoration following acute injury. Combined, these observations expose a so far under-appreciated mechanism of how cells of the immune system selectively control the differentiation of tissue progenitor cells during tissue repair and inflammation.
Abstract:
The Epidermal Growth Factor Receptor ligand Amphiregulin has a well-documented role in the restoration of tissue homeostasis following injury; however, the mechanism by which Amphiregulin contributes to wound repair remains unknown. Here we show that Amphiregulin functions by releasing bio-active TGFb from latent complexes via integrin-αv activation. Using acute injury models in two different tissues, we found that by inducing TGFb activation on mesenchymal stromal cells (aka pericytes), Amphiregulin induced their differentiation into myo-fibroblasts, thereby selectively contributing to the restoration of vascular barrier function within injured tissue. Furthermore, we identified macrophages as a critical source of Amphiregulin, revealing a direct effector mechanism by which these cells contribute to tissue restoration following acute injury. Combined, these observations expose a so far under-appreciated mechanism of how cells of the immune system selectively control the differentiation of tissue progenitor cells during tissue repair and inflammation.
Introduction:
Maintenance of tissue integrity is a critical process in the development and survival of an organism. Disruption of tissue homeostasis, through infections or injury, induces a local immune response that facilitates a tissue repair process that in many respects resembles the process of organ development. During this process of wound repair, cells of the immune system support cell proliferation and differentiation in a well-orchestrated manner ensuring successful tissue regeneration and wound closure (Aurora and Olson, 2014; Martin and Leibovich, 2005; Mescher and Neff, 2005) . Accordingly, the immune system has adapted evolutionary conserved signaling pathways, such as Transforming Growth Factor beta (TGFb) or the Epidermal Growth Factor (EGFR), that play critical roles during both physiological processes: in tissue development and wound repair. However, the exact role of these pathways, the cellular triggers and their interactions during tissue regeneration remain incomplete understood. This is in part due to the fact that both pathways have exceptionally pleiotropic functions and different ligands, whose activity is strongly influenced by factors such as the nature of ligand binding to the receptor (Freed et al., 2017) , the state of local inflammation and state of the receiving cell (Massague, 2000) .
In particular, the EGFR ligand Amphiregulin, expressed under inflammatory conditions by several types of leukocytes, has emerged as a critical player in immunity, inflammation and tissue repair (Berasain and Avila, 2014; Zaiss et al., 2015) . In numerous experimental settings, the delivery of recombinant Amphiregulin (rAREG) enhanced the process of tissue repair following injury (Arpaia et al., 2015; Burzyn et al., 2013; Jamieson et al., 2013; Monticelli et al., 2011) . Nevertheless, the underlying mechanism that underpins the contribution of Amphiregulin to tissue repair, and how it interacts with other known mediators of this process to facilitate wound healing remains largely unexplored.
We therefore sought to determine the mechanism by which Amphiregulin contributes to the restoration of tissue homeostasis following acute tissue injury. Thereby, we uncover an unexpected mechanism by which EGFR mediated signaling regulates local TGFb activity.
We found that Amphiregulin expression induced the integrin-αv mediated conversion of latent TGFβ into its bio-active form and, in turn, promoted the differentiation of tissue progenitor cells. Following acute tissue injury, this mechanism enabled tissue resident macrophage derived Amphiregulin to induce TGFβ activation and the differentiation of pericytes into collagen producing myofibroblasts, thereby causing rapid tissue revascularization and wound healing.
Results:
Amphiregulin contributes to the restoration of blood vessel integrity and lung function.
To determine the physiological relevance of endogenously expressed Amphiregulin during acute wound healing, we utilized a model of acute lung injury caused by infection with the nematode Nippostrongylus brasiliensis (Chen et al., 2012; Minutti et al., 2017b; Sutherland et al., 2014) . Following inoculation, N. brasiliensis larvae migrate through the lungs, causing significant damage to the epithelium and vasculature, which leads to loss of lung function and a drop in blood oxygen saturation (Nieves et al., 2016) . Unexpectedly, following N. brasiliensis infection, Areg -/-and C57BL/6 wt mice showed a similar extent of lung damage ( Figure 1A ) and loss of lung function ( Figure 1B) . Also, the influx of leukocytes into the lungs was similar in composition and number ( Figure S1A ) and the migration of Nippostrongylus larvae through the lungs into the intestine were not affected by Amphiregulin deficiency ( Figure S1B ). However, in the recovery phase, Areg -/-mice presented a significantly delayed restoration of lung function in comparison to wt mice ( Similarly, in a model of acute liver damage induced by injection of CCl 4 , Areg -/-and C57BL/6 wt mice showed a similar severity of liver damage ( Figure S1D ) and overall recovery following CCl 4 injection ( Figure S1E) ; however, similar to the lung, also in the liver Areg -/-mice showed a significantly delayed restoration of blood barrier function ( Figure   S1F ).
These data suggest that following acute tissue damage Amphiregulin contributes mainly to the process of wound healing by enhancing the restoration of vasculature barrier function.
Macrophage-derived Amphiregulin contributes to the restoration of vascular integrity.
To investigate the physiologically relevant cellular source of Amphiregulin following N.
brasiliensis infection, we first established a mouse strain with an Amphiregulin deficiency specifically within hematopoietic cells (Vav1-cre x Areg fl/fl ). Infecting this strain with N.
brasiliensis larvae we found a substantially delayed recovery of lung and blood barrier function; suggesting that the main source of Amphiregulin contributing to the restoration of the blood barrier function must be of hematopoietic origin . Because also T cells have been shown to produce Amphiregulin (Arpaia et al., 2015; Burzyn et al., 2013; Zaiss et al., 2006) , we assessed lung repair following N. brasiliensis infection in mice that lack T and B cells (Rag1 -/-). Since the absence of an adaptive immune system did not influence the extent of blood extravasation in Rag-/-compared to wt mice, ( Figure S2E ), we concluded that mainly innate immune cells produce Amphiregulin that contributes to the process of wound healing following N. brasiliensis infection.
To investigate the innate cell population that is producing Amphiregulin during tissue injury in more detail, we injected Brefeldin-A on day 3 post N. brasiliensis infection and performed intracellular Amphiregulin staining in lung cell suspensions. Although we detected
Amphiregulin expression by several types of innate cells, the induction of Amphiregulin expression was most pronounced in alveolar macrophages (Figure 2A ), which were also one of the most frequent types of leukocytes in the lungs over the first three days of infection ( Figure S3A ,B). Thus, in combination, alveolar macrophages appeared to be the most abundant source of Amphiregulin in infected lungs ( Figure 2A ). We therefore generated a mouse strain with a myeloid-/ macrophage-specific deficiency of Amphiregulin (LysMcre x Areg fl/fl ), which showed an alveolar macrophage-specific lack of Amphiregulin expression ( Figure S4A ). Following N. brasiliensis infection, LysMcre x Areg fl/fl mice showed an increase in inflammatory infiltrates indistinguishable to that seen in wt mice ( Figure S4B ).
However, in comparison to wt mice the genetically modified mouse strain showed an impaired restoration of lung function and blood vessel integrity following N.
brasiliensis infection and impaired induction of collagen 1a type I and type III and aSMA ( Figure 2E ).
To ensure that Amphiregulin deficiency does not impair the functionality of alveolar macrophages during lung repair, we tested the ability of alveolar macrophages from LysMcre x Areg fl/fl mice to acquire an alternative activation program and to proliferate following N.
brasiliensis infection. As we could not find any substantial differences between Amphiregulin-deficient and WT macrophage proliferation and differentiation ( Figure S4C ), we concluded that Amphiregulin is not contributing to these processes.
These data suggest that macrophage-derived Amphiregulin has no effect on alveolar macrophages themselves but directly contributes to wound repair by enhancing the restoration of blood vessel integrity following N. brasiliensis infection.
Amphiregulin induces the activation of integrin-a V and consequently the release of bioactive TGFb; thereby triggering differentiation of pericytes into myofibroblasts
Having established the source of Amphiregulin, we wanted to know the downstream effector mechanisms that underpin Amphiregulin effects on vascular repair. Mesenchymal stromal cells called pericytes are a major myofibroblast precursor cell type in the lungs and liver (Henderson et al., 2013) , known to promote integrity of blood vessels (Lindahl et al., 1997) .
Myofibroblast differentiation under inflammatory conditions is TGFb driven (Henderson et al., 2013) , a growth factor that is secreted in form of a latent protein complex that has to be released locally into its bio-active form in an integrin-a V mediated step (Gleizes et al., 1997; Henderson and Sheppard, 2013; Munger et al., 1999) . Since the delayed restoration of lung function in Areg -/-mice was directly associated with a diminished expression of the myofibroblast differentiation marker aSMA (Acta2) ( Figure 1E ), we hypothesised that Amphiregulin may induce the release of bio-active TGFb by activating integrin-a V containing integrin complexes. To test this hypothesis, we isolated primary PDGFRbexpressing pericytes, and exposed them to latent TGFb in the presence and absence of rAREG. We found that whereas rAREG treatment did not increase the transcription or the cell surface expression of integrin-a V on cultured pericytes ( Figure S5A , B), it enhanced the binding of the TGFb-latent associated protein (LAP) to pericytes ( Figure 3A) ; a process that could fully be reverted by the addition of an integrin-a V blocking antibody RMV-7 ( Figure   3A ). These data suggest that rAREG induced the activation of integrin-a V containing integrin complexes on pericytes.
In accordance with these findings, we further found that, whereas rAREG did not influence the secretion of total TGFb from primary pericytes ( Figure S5C ), it induced the release of bio-active TGFb from its latent form ( Figure 3B , upper panel; Figure S5D ). This induced release was prevented by the addition of the EGFR inhibitor Gefitinib ( Figure 3B ) and was absent in cultures of primary pericytes derived from Pdgfrb-cre x Egfr fl/fl mice ( Figure S5D ), a mouse strain with a pericyte-specific deletion of the EGFR (Henderson et al., 2013) .
Furthermore, the blockade of integrin-a V by CWHM-12 (Henderson et al., 2013 ) ( Figure 3C , upper panel; Figure S5E ), but not of TGFb-RI by an ALK5 inhibitor ( Figure 3D , upper panel), blocked the release of bio-active TGFb by rAREG treated pericytes.
In accordance with rAREG induced release of bio-active TGFb, we found that the addition of rAREG also induced the differentiation of pericytes into myo-fibroblasts ( Figure 3B , lower panel; Figure S5F ); which was an effect fully reverted by the addition of the EGFR inhibitor Gefitinib ( Figure 3B ), the integrin-a V inhibitor CWHM-12 ( Figure 3C , lower panel; Figure   S5G ) or TGFb-RI inhibition (Fig. 3d , lower panel; Figure S5G ), and which was absent in cultures of pericytes derived from Pdgfrb-cre x Egfr fl/fl mice ( Figure S5F ).
Combined, these data reveal a mechanism by which rAREG induces the activation of integrin-a V on pericytes, causing the local release of bio-active TGFb from latent TGFb and thus their differentiation into myo-fibroblasts.
rTGFb reverts the effects of Amphiregulin and pericyte-specific EGFR deficiency in vivo
Next, we sought to reveal the physiological relevance of the mechanism we had found in vitro. In accordance with our previous observation that Amphiregulin mediates TGFb activation, we found that N. brasiliensis infected Areg -/-mice show in comparison to wt C57BL/6 counterparts a diminished expression of pSMAD3, the main mediator of TGFb signalling ( Figure S6 ). This suggests that Amphiregulin also in vivo contributes to the release of bio-active TGFb. To test the link between Amphiregulin and TGFb, we injected rTGFb into N. brasiliensis infected Areg -/-mice. As shown in Figure 4A -C, the injection of rTGFb fully reverted the deficiency of Areg -/-mice in the restoration of lung function and blood vessel integrity.
To dissect this mechanism further, we analysed Pdgfrb-cre x Egfr fl/fl mice, a mouse strain with a pericyte-specific deficiency of EGFR expression ( Figure S8A ). At steady state, Taken together these data demonstrate that Amphiregulin is functioning up-stream of TGFb in the differentiation of pericytes into myofibroblasts during acute tissue damage.
Pdgfrb-cre x Egfr

Amphiregulin-induced integrin-a V activation promotes vascular repair
To address the role of Amphiregulin-induced integrin-a V activation in the restoration of lung function during N. brasiliensis infection, we inserted mini-pumps into C57BL/6 wt mice containing the integrin-a V inhibitor CWHM-12 prior to N. brasiliensis infection. We found treatment with the integrin-a V inhibitor CWHM12 had no effect on the increase in inflammatory infiltrates into the lungs and the migration of worms into the intestine ( Figure   S8A , B). Nevertheless, mice treated with the integrin-a V inhibitor CWHM12 showed a diminished restoration of blood barrier function following N. brasiliensis infection ( Figure   5A , B). This effect could fully be reverted by the administration of rTGFb but not by rAREG ( Figure 5A, B) . These data clearly demonstrate that Amphiregulin effects occur upstream of integrin-a V activation.
Finally, to directly demonstrate the involvement of integrin-a V on pericytes during vascular repair, we generated pericyte-specific integrin-a V -deficient mice (Pdgfrb-cre x Itgav fl/fl ) and infected these with N. brasiliensis larvae. As shown in Figure 5C These experiments demonstrate that also in vivo Amphiregulin contributes to the restoration of tissue integrity by inducing integrin-a V mediated TGFb release specifically on pericytes.
Discussion:
Our data reveal a novel mechanism by which Amphiregulin induces the activation of integrin-a V complexes on pericytes and in this way the local release of bio-active
TGFb. This in turn induces their differentiation into collagen producing myofibroblasts, which critically contributes to the restoration of vascular integrity in injured tissues.
This unexpected link between Amphiregulin-induced EGFR signaling and TGFb activation may explain, in addition to its role in wound healing, also several formerly described effects Data represent mean ± SEM; results for individual mice are shown as dots.
References:
Arpaia, N., Green, J.A., Moltedo, B., Arvey, A., Hemmers, S., Yuan, S., Treuting, P. Traverse, S., Gomez, N., Paterson, H., Marshall, C., and Cohen, P. (1992) . Supplemental figure 8 
